The 2022 Parkinson’s drug development pipeline report

The 2022 annual report, outlining the current development pipeline of new drug-based treatments for Parkinson’s, has been published.


Parkinson’s Clinical Study Group

Cure Parkinson’s is funding Professor Oliver Bandmann at the University of Sheffield to establish a nationwide infrastructure for a study group focused specifically on conducting clinical trials for Parkinson’s.


News CP news

2022 Gulls’ Eggs Luncheon raises over £90k for Parkinson’s research

On Tuesday 10 May, the City’s leading wealth management professionals gathered in the historic Merchant Taylors’ Hall for the 34th annual Gulls’ Eggs Luncheon, raising over £72k for Parkinson’s research.


News Research news

Phase 1a trial findings of iLCT prioritised drug, Anle138b

The findings of the phase 1a clinical trial of Anle138b have been published. Anle138b is a new drug that targets the build-up of alpha synuclein, a protein that clumps together in Parkinson’s.


News Research events

Spring Research Update Meeting 4 May: recorded to watch again

Theme: Why diabetes drugs might be an important potential line of treatment for Parkinson’s. The meeting was recorded and is available to re-watch now